RETHINK-ALZ
Simufilam 100 mg for Mild to Moderate Alzheimer’s Disease
RECOVER VNS
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
X-TOLE: XEN1101 as Adjunctive Therapy in Focal-onset Epilepsy, with an Open-Label Extension
A clinical research study is underway for people with focal epilepsy currently taking 1-3 anti-epileptic drugs that are still experiencing frequent seizures. Three doses of investigational drug are being studied and some participants will be assigned placebo. All participants will receive active study on the extension study.
PIONEER T3D: Clinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate Alzheimer’s Disease Subjects
PIONEER T3D: Clinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate Alzheimer’s Disease Subjects Inclusion Criteria Age 55-90 years Have a reliable study partner, an identified adult who has sufficient contact to knowledgeably report on the subject’s daily cognition, function, behavior, safety, compliance and adherence. Have a clinical diagnosis of mild-to-moderate AD Visual and
TRAILBLAZER-2: Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer’s Disease
The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer’s disease.
Alzheimer’s Disease Neuroimaging Initiative 3 (ADNI3)
The Alzheimer’s Disease Neuroimaging Initiative (also known as ADNI) is a historic study of brain aging looking to help change the future for this disease.
Alzheimer’s Disease Neuroimaging Initiative 3 (ADNI3) Read More »
Break the stigma; mental health in sports is just as essential as physical health
Despite efforts to bring more awareness mental health, a stigma persists both socially and in athletic culture. Below, Michael Asbach, a Doctorlly trained Psychiatric Physician Assistant at DENT Behavioral Health, answers some questions about mental health and sports. How big of a role does mental health play in sports? Mental health has an impact on
Break the stigma; mental health in sports is just as essential as physical health Read More »
CGBG Study
We are looking for adults ages 18 to 55 who have been diagnosed with migraine. The CGBC Study will consist of five visits over a period of up to five weeks.
2021 Neurodiagnostic Week
Neurodiagnostic Week 2021 takes place from April 18-24. At DENT Neurologic Institute, this is one of many ways we can honor and celebrate our Neurodiagnostic professionals for their contributions by demonstrating their value to quality healthcare. The purpose of the week is to acknowledge the year-round efforts of the Neurodiagnostic professionals around the world. It
2021 Neurodiagnostic Week Read More »